Detecting Traumatic Intracranial Hemorrhage With Microwave Technology

NCT ID: NCT02728908

Last Updated: 2020-01-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

250 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-04-30

Study Completion Date

2019-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An open study evaluating the diagnostic accuracy of a microwave-based device to detect traumatic intracranial hemorrhage (TICH), by comparing measurements on trauma patients with confirmed vs excluded TICH

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This open study will enrol trauma patients admitted to the Trauma Unit, Department of Surgery at Sahlgrenska University Hospital/Sahlgrenska. It will compare patients where TICH has been confirmed by CT (group A) to patients where CT has ruled out TICH (group B). Patients will be asked to participate in the study as early as possible after admission and CT scan. After physical examination, checking inclusion/exclusion criteria, and after informed consent has been acquired, the baseline microwave-based measurement will be performed. The diagnostic procedure is estimated to take 15 min; whereof total subject measurement time will be less than five minutes. Follow-up microwave measurements will be performed in conjunction with any follow-up CTs performed as part of the standard of care, during the hospitalized treatment period. If no follow-up CTs are performed as part of the standard of care, only the baseline microwave measurement will be performed.

Safety will be followed throughout the study, and a safety follow-up will be performed 12 hours after the last microwave-based investigation is finalized.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Traumatic Intracranial Hemorrhage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Medfield Strokefinder MD100

Measurement with Medfield Strokefinder MD100

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient admitted to Sahlgrenska University Hospital for trauma care.
* Patient deemed clinically stable.
* Patient should have a Glasgow Coma Scale rating of \> 14
* TICH confirmed (group A) or ruled out (group B) by CT, performed within the latest 12 hours.
* Patient ≥ 18 years of age.
* Patient has signed the Informed Consent Form.

Exclusion Criteria

* Patient has confirmed or suspected skull fracture.
* Patient has confirmed or suspected cervical spine fracture.
* The diagnostic procedure is deemed to interfere with the standard of care.
* Patient has a shunt or other foreign object implanted intracranially.
* Patient has agraffes/other metal parts, thick (\> 1 cm) bandage, or other foreign materials attached to the head that are deemed to interfere with the diagnostic procedure.
* Any other condition or symptoms preventing the patient from entering the study, according to the Investigator's judgment.
* Females who are pregnant.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medfield Diagnostics

INDUSTRY

Sponsor Role collaborator

Chalmers University of Technology

OTHER

Sponsor Role collaborator

Hans Granhed

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hans Granhed

Sponsor-Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hans Granhed, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Sahlgrenska University Hospital, Department of Surgery, Trauma Unit

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sahlgrenska University Hospital, Department of Surgery, Trauma Unit

Gothenburg, Västra Götaland County, Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TICH 01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

TBI MR Study 3 Houston Methodist
NCT02218216 TERMINATED NA